News

NBC New York5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC New York
The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular ...
Scientific American2d
Could China’s New GLP-1 Drugs Beat Out Ozempic?
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Pharmabiz9d
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...
NBC Chicago5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC Chicago
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S.
NBC 10 Philadelphia5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC10 Philadelphia
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S.
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, ...
NBC DFW5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC 5 Dallas-Fort Worth
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S.
NBC Los Angeles5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC Los Angeles
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...
NBC 6 South Florida5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC 6 South Florida
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...
NBC Connecticut5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC Connecticut
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...
NBC Washington5mon
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use - NBC4 Washington
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function. Skip to content Main Navigation ...